Driving Endovascular Therapies Edwards has long been a leader in vascular therapies, including our industry standard Fogarty embolectomy catheters, used to remove blood clots from the limbs. We are leveraging our vast experience in this area to explore new, less-invasive therapies, such as our Lifepath AAA Endovascular Graft System. A potentially dangerous AAA forms in the aorta, the body’s primary circulatory channel, when a portion of the aortic wall weakens and bulges outward. While conventional AAA surgery is complex and requires long recovery times for patients, Edwards’ Lifepath AAA Endovascular Graft is permanently implanted within the affected area of the aorta via a catheter-based delivery device. The procedure is much less invasive than direct surgery and can enable patients to recover more quickly. Edwards’ Lifepath AAA system features a full-thickness graft material and is the only balloon-expandable endovascular graft designed for the treatment of AAA. The Lifepath AAA system is available commercially in Europe and is currently in Phase II clinical trials in the United States.